This bill amends the Controlled Drug Act to clarify exceptions to the existing 34-day limit on prescriptions for controlled drugs, specifically for schedules II and III. The bill repeals and reenacts RSA 318-B:9, IV, allowing for certain exceptions where prescriptions can be filled for more than a 34-day supply. Notably, it permits prescriptions for commercially packaged controlled drugs, such as metered sprays and topical preparations, to be filled for up to 60 days. Additionally, it allows prescriptions for amphetamines and methylphenidate hydrochloride to be filled for up to 90 days when used for specific conditions like attention deficit disorder.

Furthermore, the bill introduces provisions for prescriptions related to androgen treatments. It allows prescriptions for topically applied and injectable androgens, prescribed for chronic low testosterone, to be filled for up to 92 days. However, for injectable androgens, the prescription must include a statement from the prescriber confirming the treatment purpose and evidence that the patient has previously filled 12 monthly prescriptions from the same medical practice. The act is set to take effect 60 days after its passage.